Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

BACKGROUND: Although the addition of bevacizumab significantly improves the efficacy of chemotherapy for advanced breast cancer, regulatory concerns still exist with regard to the magnitude of the benefits and the overall safety profile. METHODS: A literature-based meta-analysis to quantify the magn...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3120715/
https://ncbi.nlm.nih.gov/pubmed/21569417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-54
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker